BmKCT interacts specifically with human glioma (SHG-44) cells, but not with normal astrocytes, as a Cl‒ channel blocker [54] and inhibits the invasion and migration of rat glioma (C6) cells by antagonizing MMP-2 [55]. Here, MMP2 is linked to central nervous system cancer.